GENI vs SRTA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
GENI
SRTA
Investment Advisor Scores
SRTA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GENI | SRTA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 56.8182 | 138.8889 | GENI |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 64.7% | 60.7% | GENI |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.4/100 | 30.9/100 | GENI |
| Profit Margin | -23.0% | 15.7% | SRTA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GENI
MarkupPrice above SMA50, rising 50-day trend (14.0% over 20 days), RSI 60
SRTA
NeutralMixed signals - no dominant trend phase, RSI 66
Fundamentals Snapshot
| Metric | GENI | SRTA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.5 | 1784.9 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.6% | 0.6% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | -0.1% | -0.1% |
| EPS | -0.70 | -0.28 |
| Dividend Yield | — | — |